Clinical Trial Update: Baricitinib Therapy in COVID-19 [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on baricitinib therapy for COVID-19 with pneumonia conducted in Phase 2 and Phase 3 stages; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Fabrizio Cantini | Conditions: COVID, Pneumonia | Phase 2, Phase 3 | Status: COMPLETED